Compare Invesco DB Agriculture Fund (DBA) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco DB Agriculture Fund vs Tempus AI — how do they compare? Invesco DB Agriculture Fund trades at $28.48 (market cap $1.32B), while Tempus AI trades at $71.8 (market cap $12.58B). The key difference: Tempus AI is far larger — about 9.5× Invesco DB Agriculture Fund's market cap, and Invesco DB Agriculture Fund is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Invesco DB Agriculture Fund for 24 Days and Tempus AI for 22 Days on average.
| DBA | TEM | |
|---|---|---|
Market Cap | $1.32B | $12.58B |
Volume | 771,657 | 7,444,569 |
52-Week High | $29.49 | $99.28 |
52-Week Low | $25.44 | $41.55 |
Typical Hold Time | 24 Days | 22 Days |
Sector | — | Broad Market / Factor |
Enterprise Value | — | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DBA (Invesco DB Agriculture Fund ETF) trades at $28.42, down 0.25% on the day, with a bearish technical signal from moving averages but neutral oscillators. The fund has returned 12.4% year-to-date, closely tracking the S&P 500, supported by agricultural commodity strength from weather risks and geopolitical tensions. Recent news highlights DBA's consolidation near all-time highs with a 3.25% yield, though it faces a high expense ratio of 0.85%.
Outlook remains mixed with bullish agricultural trends from El Niño and demand catalysts balanced by sector volatility and expense concerns. Key risks include commodity price swings and geopolitical developments, while institutional sentiment leans neutral with a Hold rating from analysts citing momentum versus cost trade-offs.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Invesco DB Agriculture Fund
The index, which is comprised of one or more underlying commodities ("index commodities"), is intended to reflect the agricultural sector. The fund pursues its investment objective by investing in a portfolio of exchange-traded futures.
Read more on DBA →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
